Par Drugs And Chemicals Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
PAR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Par Drugs and Chemicals Limited submitted three annual declarations under SEBI Regulation 31(4) on April 2, 2026. Promoters Mr. Falgun Vallabhbhai Savani (Chairman & MD), Mr. Jignesh Vallabhbhai Savani (Director & CEO), and the entire Promoter Group declared that no new encumbrances (pledges, liens, or other restrictions) on company shares have been created during Financial Year 2025-26, beyond what was already disclosed to the stock exchange. The promoter group consists of 6 members including the Savani family members. This is a routine compliance filing required annually from all listed company promoters.
Positive for retail investors as the declaration confirms promoters have not taken on additional debt against their shareholdings. No increase in pledged shares reduces the risk of potential share sales by lenders in case of margin calls.